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Functional rescue of the glomeruloscierosis phenotype in Mpvl7 mice
by transgenesis with the human Mpvl7 homologue. The germ line
insertion of a defective retrovirus into the Mpvl7 gene of mice is
associated with a recessive phenotype. Mice homozygous for the integra-
tion develop glomeruloscierosis at a young age. The phenotype resembles
human glomerulosclerosis in its physiological parameters as well as in
histology. A human homologue of the Mpvl7 gene has been identified,
isolated and analyzed. We here show that this gene, which has a role in the
production of reactive oxygen species, can rescue the phenotype of Mpvl7
deficient mice when introduced by transgenesis. This provides formal
proof for the hypothesis that the phenotype is caused by the loss of
function of the Mpvl7 gene. It also provides evidence for the functional
conservation of the Mpvl7 gene in mammals and points to a potential role
of this gene in human kidney disease.
The Mpvl7 mouse strain was generated by insertion of a
defective retrovirus into the germline of mice. Mice homozygous
for the integration develop a phenotype of glomeruloscierosis at
age three months or older and die later as a consequence of renal
failure. A gene was identified at the integration site and its
expression was found to be completely abolished by the integra-
tion [1]. This gene, the Mpvl7 gene, is therefore a good candidate
for a recessive disease gene causing glomerulosclerosis. A human
homologue has been identified, isolated and studied [2]. It is a
single copy gene with very high homology to the mouse gene. Both
genes code for proteins of 176 amino acids in size, and we have
recently identified the Mpvl7 gene product as a player in the
peroxisomal reactive oxygen metabolism [3]. We show here that
the human homologue expressed from a heterologous promoter
in the kidney after introduction as a transgene can rescue Mpvl7
homozygous animals from developing glomerulosclerosis. This
provides proof that the loss of Mpvl7 gene expression is indeed
causal to the phenotype. It also demonstrates functional homol-
ogy between the mouse and the human gene and thereby under-
lines the value of the Mpvl7 deficient mouse as a model of human
glomerulosclerosis.
Methods
Cloning of the rescue construct
The mouse MT-l promoter was cut out of the vector Mthgh-
Dhfr (provided by E. Wagner, Vienna, Austria) [4, 51 with Eco RI
Received for publication December 15, 1994
and in revised form February 14, 1995
Accepted for publication February 16, 1995
© 1995 by the International Society of Nephrology
80
and Bam HI. The 1.8kb fragment was gel-purified and cloned into
pBluescript II KS using the above-mentioned restriction sites.
From a human Mpvl7 cDNA, containing intron 6 due to incom-
plete splicing [2], the vector p6/2 was released with Sac I, the 1.2
kb fragment isolated and ligated into the according site of the
pBluescript already containing the MT promoter. The correct
orientation of the eDNA was verified by several asymmetric
digests. The MT-Mpvl7 (6/2) fragment was then released with
BssHII from the pBluescript vector, purified over an agarose gel,
and used for microinjection of mouse zygotes.
Generation of transgenic mice and genolyping
The 3 kb promoter/gene DNA fragment was dissolved in
injection buffer (10 mi Tris pH 7.5, 0.1 mrvi EDTA) at a
concentration of 5 ng/j.Ll. The DNA solution was sterile filtered
and injected into the pronuclei of zygotes of female Balb/c mice
mated to male Balb/c or Mpvl7 mice (the latter are on a
CFW/Balb/c background).
Females were superovulated by intraperitoneal injections of 10
U of pregnant mare serum (PMS, Sigma) and after 48 hours with
10 U of human chorionic gonadotropin (HCG, Sigma). Eggs
surviving microinjection were transferred into the oviducts of
pseudopregnant foster mice according to Hogan, Constantini and
Lacy [6]. Mice born were tested for the integration of the
construct DNA by Southern blot analysis of tail DNA. For this
purpose the DNA was digested with Sac I and hybridized with a
human eDNA probe [2]. The mutation of the endogenous Mpvl7
gene was monitored accordingly, whereby the tail DNA was
restricted with Bam HI and hybridized with a genomic 350 bp Sau
3A restriction fragment localized close to the integration site
within the Mpvl7 gene [1]. Hybridizations and washes were
carried out under high stringency [3].
Reverse transcnptase-PCR (RT-PCR)
Total RNA was prepared from mouse kidneys by the guanidini-
umisothiocyanate method [7] and was enriched for polyade-
nylated RNA. For that 300 g of total RNA were incubated
overnight with oligo(dT)-cellulose type VII (Pharmacia) in 500
mM NaC1, 20 mivi Tris-HC1, pH 7.4, 10 ms EDTA, 0.1% SDS, and
proteinase K (300 g/ml). After several washing steps with 400
mM NaCI, 20 mM Tris pH 7.4, 10 mvt EDTA, 0.2% SDS and 100
mM NaCI, 20 mi Tris pH 7.4,10 mivi EDTA, 0.2% SDS, RNA was
eluted with diethyl pyrocarbonate (DEPC) treated water and
ethanol precipitated. Subsequently the RNA pellet was purified
with phenol and chloroform and again precipitated. One hundred
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Fig. 1. The human MT Mpvl7 rescue gene
constmct. The human Mpvl7 cDNA gene
including intron 6 is under control of the mouse
metallothioneine (MT) promoter. The 3 kb
BssH II restriction fragment was used for the
generation of transgenic mice.
nanograms of each polyA RNA were then used as a template to
synthesize Mpvi7 cDNA in 50 mM KC1, 10 mM Tris-HC1 (pH 8.3),
5 mM MgCl, 1 m of each dNTP (Boehringer, Mannheim,
Germany), 10 units of RNase inhibitor (USB), 2.5 .LM of oligo
d(T) primer (Boehringer), 2.5 units of avian myeloblastosis virus
reverse transcriptase (AMV-RT, Promega) and filled up to 20 p1
with water. The samples were incubated for 20 minutes at 42°C
and subsequently denatured at 95°C for 5 minutes. For the PCR
reaction the MgCI2 concentration was adjusted to 2 m and the
final reaction volume was scaled up from 20 p1 to 100 21. In
addition, the samples were supplemented with Mpvl7 specific
primers from the human eDNA to a final concentration of 0.15 pM
and 2.5 units of Taq polymerase (Amersham) were added. The
sequences of the primers used are:
is: 5'GAA11TCGAGGCTCGGCGCTCAGGAAGC3' and
4r: 5 'GAATFCAAACGATGGAGTGAGGCAGGC3'
representing nucleotide positions 9—29 (is) and 582—561 (4r),
respectively [2]. After 35 cycles 20 p1 of each sample were
analyzed on a 1% agarose gel. The observed size for correct
eDNA expression was as expected 585 bp [21. In the RT negative
controls the identical procedure was carried out omitting the
reverse transcriptase enzyme.
Histology
Kidneys from homozygous and heterozygous Mpvl7 mice as
well as MT670 mice were fixed in 4% buffered paraformaldehyde,
dehydrated and embedded in paraplast. Three micrometer sec-
tions were prepared, stained with PAS (Sigma Diagnostics) and
Masson trichrome stain.
Results
Construction of a vector expressing the human Mpvl 7 gene and
generation of lransgenic lines
The complete human Mpvl7 eDNA was cloned previously as a
fragment of 1.0 kb [21. In the process of this procedure an
incompletely spliced cDNA molecule was also isolated, in which
the 263 bp intron between exon 6 and exon 7 had not been
removed [2]. For several reasons we used this molecule to
assemble the expression vector. Firstly, it has been reported
earlier that introns enhance the expression of transgenes in
general [8, 9]. Secondly, when the transgene expression is ana-
lyzed by reverse transcription PCR, artifacts due to contamination
of the mRNA with genomic DNA can be readily excluded on the
basis of the size of the amplification product (see below). We
placed this gene, including its 3'untranslated region and its polyA
addition signal, under the control of the mouse metallothioneine
I promoter contained on a 1.8 kb fragment 1101. This promoter
has been used before successfully to express transgenes in various
tissues of mice [ii]. Figure 1 depicts the resulting construct used
for microinjection. Mice developed from injected eggs were tested
for the integration of the construct DNA by Southern blot analysis
of tail DNA. Therefore, the tail DNA was cleaved with Sac I
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Fig. 2. Genotyping of transgenic mice. Southern blot analysis of tail DNA
of the transgenic mice (numbers 1 to 7 indicated at the bottom). Top
panel. Endogenous Mpvl7 locus. BamHI cleaved DNA was hybridized
with a 350 bp Sau 3A fragment diagnostic for the mutation [1]; WT: wt
Mpvl7 allele; MA: mutated Mpvl7 allele. Lower panel. Presence of the
MT-Mpvl7 transgene. Sac I digested DNA was hybridized with a fragment
representing the human eDNA. TG: transgene fragment. EG: cross
hybridizing endogenous Mpvl7 locus. The kidney histology of mouse 5
(homozygous mutant Mpvl7; transgenic for MT-Mpvl7) is shown in
Figure 3 e and f.
restriction endonuclease and hybridized to the radiolabeled hu-
man eDNA fragment [2]. The transgene was detected as hybrid-
izing fragment of 1.2 kb as shown in the bottom of Figure 2 (lower
band). The second transgene specific fragment (TG) presumably
represents a transition fragment at the border of the transgene
integration generated by the loss of the Sac I site flanking the
construct at its 3'end. Under this assumption, the number of
tandem transgene copies in the particular strain displayed in
Figure 2 is about 15, judging from the intensity of the transgene
specific bands. Despite of the stringent hybridization conditions
the endogenous Mpvi7 locus cross hybridized with the human
eDNA. Figure 2 shows the analysis for one of the three transgenic
strains generated. None of these displayed any obvious pheno-
type.
Rescue of the glomerulosclerosis phenotype of Mpvl 7 mice by
genetic introduction of the human homologue
The Mpvl7 mouse strain contains a silent retroviral insert in
both alleles of the Mpvi7 gene. We were interested to investigate
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Fig. 3. Representative histology (PAS stain) of six months-old mice with different Mpvl7 genotype. a (X 140) and b (X550). Heterozygous Mpvl7. c (X 140)
and d (X430). Homozygous mutant Mpvl7 mice demonstrating an early stage of glomerular sclerosis; tubular interstitial changes have not yet
developed. e (x270) and f (x550). Strain MT670 (homozygous mutant Mpv 17, transgenic for MT-Mpvl7; mouse 5 in Fig. 2).
whether the human gene, expressed as a transgene, could corn- with hornozygous Mpvl7 mice. This is possible because Mpvl7
plement the glomeruloscierosis phenotype in such mice. There- hornozygotes are fertile and live long enough to reproduce. To
fore transgenic mice carrying the human Mpvl7 gene were mated follow the mutant endogenous allele in these breedings, we used
kb
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ular histology (e,f). Thus, on this level, transgene-dependent
successful rescue was seen.
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Fig. 4. Analysis of the transgene expression. Transgene expression was
examined using the RT-PCR technique on poiyA RNA of kidneys from
different mice. Lanes I and 5. Homozygous mutant Mpvl7 mouse. Lanes
2 and 6. MT670 mouse (mouse 5 in Fig. 2). Lanes 3 and 7. Human GM637
fibroblasts. Lane 4 and 8. RSV 7 cells, murine transfected fibroblasts,
constitutively expressing the human Mpvl7 gene [3]. Lanes ito 4. Reverse
transcriptase was omitted from the RT-PCR protocol as control for DNA
contamination. Lanes 5 to 8. Complete RT-PCR protocol. Lane 9.
Amplification on the human cDNA clone p21 [2]. Lane 10. Amplification
on the MT-Mpvl7 rescue construct, containing intron 6. For correctly
spliced transgene derived mRNA a product of 585 bp is expected (lane 9).
Unspliced transgene mRNA or contaminating transgene DNA results in a
fragment of 848 bp (lane 10).
a polymorphism between the wt and mutated alleles [1]. In
particular, a genomic probe (Sau 3A 350) from the integration site
detects a 3 kb fragment in the wt allele (WT in Fig. 2) as opposed
to a 6 kb fragment (MA in Fig. 2) in the mutant allele in Barn Hi
digested DNA. Thus, heterozygous mice show both the WT and
the MA band, whereas hybridization only to the MA band
indicates homozygosity for the mutation. The initial breeding
produced transgene positive Mpvl7 heterozygous offspring which
did not show any phenotype. These were interbred and the
genotype of the resulting F2 generation was analyzed. Homozy-
gous Mpvl7 mice carrying the MT-Mpvl7 transgene (this geno-
type is shown in lane 5 of Fig. 2) were interbred further and
designated MT670. So far over 50 animals of this genotype were
produced, none of which died of or developed symptoms of
nephrotic syndrome. By contrast, all Mpvl7 homozygous mice
without the human transgene eventually developed the disease
and died from it, although the onset of disease was variable due to
the genetic heterogeneity of the background strain. Thus, the
human transgene obviously affects the survival of Mpvl7 mice. To
determine whether the presence of the transgene prevented these
mice from developing the glomerulosclerosis phenotype, several
animals were sacrificed at the age of six months and analyzed
histologically. A standard PAS staining is shown in Figure 3
demonstrating the sclerosis in Mpvi7 mutant mice (c,d), while the
heterozygous control mice showed no pathology in the glomeruli
(a,b). Likewise, mice of the MT670 strain showed normal glomer-
Expression of the human transgene in the kidney of MT670 mice
To investigate transgene expression mRNA was analyzed pre-
pared from the kidneys of MT670 mice and Mpvi7 mice, respec-
tively, and reverse transcription PCR analysis was performed (Fig.
4). The primers used in this analysis specifically detected trans-
gene derived transcripts, because they were chosen from the 5'
and 3' untranslated regions of the human cDNA, where the
murine and human sequences significantly differ [2]. A product of
the expected size of 585 bp for authentic, fully spliced mRNA was
._ detected in the sample from the MT670 mouse (lane 6). Likewise,
a band of the same size was detected in human GM637 fibroblasts
(lane 7), as well as in murine fibroblasts, transfected with a
construct constitutively overexpressing the human Mpvi7 gene
(lane 8) [31. By contrast, no expression was detected in nontrans-
genie Mpvl7 homozygotes (lane 5). The amplification products do
not originate from contaminating genomic DNA in the RNA
samples because the transgene represents a eDNA in which exon
6 of 263 bp has not been removed [2]. Amplification of genomic
transgene DNA therefore results in a larger fragment, as shown in
a control reaction (lane 10). These results demonstrate transgene
expression in the kidney of MT670 mice, and we conclude that the
expression of the human homologue in these mice complements
for the loss of Mpvl7 function in homozygous Mpvl7 mutant
mice. This functional rescue not only proves that the phenotype in
the mutant is caused by the loss of function of the Mpvl7 gene,
but is also evidence for the functional homology of the two genes
in mouse and humans.
Discussion
In contrast to transgenic mouse or rat models where glomeru-
loscierosis has been dominantly induced by expression of a foreign
transgene [12—16], the Mpvl7 mouse strain is the only recessive
mouse model of glomerulosclerosis so far. Therefore, it defines an
endogenous gene whose loss of function correlates with this
disease and constitutes a valuable genetic animal model of the
human disorder. The gene inactivated by the retroviral insertion
therefore is a candidate for a recessive disease gene in mice. The
experiments described here show that the failure to express the
gene is causal to the phenotype, since complementation can be
achieved by transgenesis.
The Mpvl7 gene product is a peroxisomal protein of 176 amino
acids in humans and mice alike. We have shown recently that this
protein is involved in the generation of reactive oxygen species
(ros), most likely superoxide [31. Remarkably, the Mpvl7 defect
results in decreased rather than increased ros levels, which is in
contrast to chemically-induced glomeruloscierosis models in ro-
dents. There, a direct action of ros on the glomerular basement
membrane has been established [17]. Thus, we assume that the
mechanisms inducing the disease are triggered by low intracellular
superoxide levels, and preliminary evidence suggests that the
presence of the Mpvl7 gene product regulates the expression of
genes involved in glomerular basement membrane turnover
(Reuter, Zwacka and Weiher, manuscript in preparation). In this
regard, it is intriguing that Mpvl7 protein expression is normally
found in podocytes (Waldherr, Zwacka and Weiher, unpublished
results), the cell type mostly responsible for the biosynthesis of the
glomerular basement membrane [181. Although the combined
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evidence may suggest that the kidney disease constitutes the
primary defect in the mutant mice, thus far it cannot be ruled out
that it may be a manifestation of an earlier defect elsewhere in the
organism. The latter is in agreement with the widespread expres-
sion of the Mpv 17 gene in normal mice [1]. To distinguish
between these two possibilities, the transgenic approach will be
used to study whether rescue can be achieved by Mpvl7 expres-
sion targeted to different tissues.
In the MT670 mice, the level of transgene expression is very low
and cannot be detected by Northern blot analysis (data not
shown). However, these low amounts, which we have demon-
strated in the kidney of these mice, are sufficient to rescue the
phenotype.
The human Mpvl7 protein can functionally complement the
missing Mpvl7 protein in the mutant mice. This points to a
conservation of its function between mammals and renders the
Mpvl7 gene a candidate for a human disease gene. So far, we
have analyzed several cases of familial glomerulosclerosis and not
found alterations in the respective Mpvl7 genes. Among them we
have excluded a contribution of the Mpvl7 gene product to the
most frequent hereditary glomeruloscierosis, the so-called Finnish
nephrosis [191. However, the Mpvl7 gene still remains an inter-
esting candidate gene for these types of diseases. Understanding
the mechanisms by which the Mpvl7 mice develop disease may
also help to understand the mechanisms of development of the
more frequent acquired glomeruloscieroses, for instance, as a
consequence of diabetes.
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